The AI Behind DeepMind’s AlphaFold – and its Implications for the Future of Drug Discovery
This is a contributed article by Kristóf Zsolt Szalay. Kristóf is Founder and CTO at Turbine.AI, and holds a PhD in…
•

Kristof Zsolt Szalay is Founder and CTO of Turbine.ai, a simulation-driven drug discovery company - and guest contributor for Emerj Artificial Intelligence Research. Kristof holds a PhD in molecular biology and bioinformatics from Semmelweis University.